«This study is important because it has the potential to change the way
we approach kidney transplantation,» says the study's principal investigator, E. Steve Woodle, MD, UC Health transplant surgeon and director of the division of transplantation at the UC College of Medicine, who adds: «This also may benefit 10 to 20 percent of heart and pancreas transplant candidates who often have such high levels of antibodies that transplantation is nearly impossible.»
Not exact matches
As for treatments, the paper states, «Stem cell
transplantation may prove to be a viable
approach to treat diseases such as suPAR - associated
kidney disease.»
Stanley C. Jordan, MD, director of
Kidney Transplantation and Transplant Immunology, is a prominent pioneer in designing treatment
approaches that have significantly reduce the amount of antibodies, thereby reducing the risk of organ rejection.
(4) Conduct a program for end - stage and renal disease research, to include support of projects and demonstrations for providing special services (including
transplantation and dialysis), artificial
kidneys, and supplies * necessary for the REHABILITATION of individuals suffering from such disease and which will (A) insure dissemination of research findings, (B) provide encouragement and support for initiatives and new
approaches by individual and institutional investigators, and (C) establish and maintain close working relationships, with other governmental and voluntary institutions and organizations engaged in similar efforts, in order to unify and coordinate scientific efforts, encourage joint planning, and promote the interchange of data and reports among investigators in the field of end - stage renal disease.